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Abstract
Purpose. We hypothesized that adventitial transplantation
ofbloodoutgrowthendothelialcells(BOEC)tothevein-to-
graft anastomosis of polytetrafluoroethylene grafts will re-
duce neointimal hyperplasia by reducing hypoxia inducible
factor-1α(HIF-1α),byincreasingangiogenesisinaporcine
model of chronic renal insufficiency with haemodialysis
polytetrafluoroethylene grafts. Because matrix metallopro-
teinases (MMPs) have been shown to be involved with an-
giogenesis, the expression of MMPs and their inhibitors
was determined.
Methods. Chronic renal insufficiency was created by
subtotal renal infarction and 28 days later, arteriovenous
PTFE grafts were placed bilaterally from the carotid artery
tothejugularvein.Autologousbloodoutgrowthendothelial
cells labeled with Lac Z were transplanted to the adventi-
tia of the vein-to-graft anastomosis using polyglycolic acid
scaffoldingandscaffoldingonlytootherside(control).An-
imals were killed 14 days later and vessels were explanted
from the vein-to-graft anastomosis of both sides and under-
went immunohistochemical analysis, western blotting and
zymography for HIF-1α, MMP-2, MMP-9, TIMP-1 and
TIMP-2. BOEC were also made hypoxic and normoxic for
12, 24 and 48 h to determine protein expression for MMPs
and TIMPs.
Results. Under hypoxia, BOEC significantly increased the
expressionofproMMP-2by12handTIMP-2by24hwhen
compared to normoxic cells (P < 0.05). Transplantation of
BOECresultedinasignificantdecreaseinbothHIF-1αand
intima-to-media ratio with a significant increase in both
pro and active MMP-9 when compared to control vessels
(P < 0.05). MMP-9 activity was localized to the neointima
ofthetransplantedvesselsbyimmunohistochemistry.There
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was increased CD31 density with engraftment of BOEC
cells into the neointima of both the transplanted vessels
compared to controls (P = NS).
Conclusion. Transplantation of BOEC resulted in a sig-
nificant decrease in intimal hyperplasia and HIF-1α with
a significant increase in both pro and active MMP-9 that
was localized to the neointima of transplanted vessels. The
increase in MMP-9 offers a possible mechanism for an-
giogenesis and the reduced intima-to-media ratio. Further-
more, we observed that BOEC had homed to the neoin-
tima of the contralateral vessels that had increased levels of
HIF-1α, suggesting that hypoxia may be an important stim-
ulus for BOEC migration.
Keywords: blood outgrowth endothelial cells;
haemodialysis graft failure; hypoxia; restenosis; vascular
biology
Introduction
In the United States, over half of the patients undergo-
ing chronic haemodialysis require polytetrafluoroethylene
(PTFE) grafts for vascular access [1]. The patency of PTFE
haemodialysis grafts has been reported to be 50% at 1 year
and 25% at 2 years [2]. Data suggest that haemodialysis
vascular access graft failure results primarily from venous
stenosisformationcausedbyintimalhyperplasiaandsubse-
quent thrombosis at the vein-to-graft anastomosis [3]. The
intimal hyperplasia is composed of proliferating vascular
smooth muscle cells with accompanying matrix deposition
[4]. In patients with failed grafts, angiogenesis has been
shown to occur within the neointima and adventitia along
with increased expression of vascular endothelial growth
factor (VEGF) and other growth factors [4]. These obser-
vations from clinical specimens suggest that angiogenesis
plays an important role in haemodialysis vascular access
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graft failure; however, the temporal sequence and exact
nature of its relationship to intimal hyperplasia formation
remains unclear.
Hypoxia is a fundamental stimulus for angiogenesis. It
mediates gene expression of several important angiogenic
factors through increased expression of hypoxia inducible
factor-1 alpha (HIF-1α) including vascular endothelial
growth factor-A (VEGF-A), vascular endothelial growth
factor receptor-1 (VEGF-R1), matrix metalloproteinase-2
(MMP-2)andothers[5].Arecentstudyfromourlaboratory
showed that there was significantly increased expression of
HIF-1α in tissue removed from the venous stenosis when
compared to control veins in a porcine model of chronic re-
nal insufficiency with arteriovenous PTFE haemodialysis
grafts [6]. Moreover, in clinical specimens removed from
patients with PTFE haemodialysis grafts, there was signif-
icantly increased expression of HIF-1α when compared to
control veins [7]. Finally, there have been several studies in
experimental animal models of atherosclerosis and arterial
restenosis that have showed that there is increased hypoxia
(HIF-1α) associated with the pathologic process [8]. Taken
collectively, these data suggest a role for hypoxia (HIF-1α)
in haemodialysis graft failure and alleviating hypoxia may
help reduce intimal hyperplasia.
MMPs, specifically MMP-2 and MMP-9, and their
endogenous inhibitors, tissue inhibitors of matrix met-
alloproteinases (TIMPs), play a key role in haemodia-
lysis graft failure, vein graft remodeling [9] and an-
giogenesis [10]. Previous work from our laboratory has
demonstrated early up-regulation of MMP-2, in a porcine
model of haemodialysis vascular access graft failure that
corresponded with increased cell migration from the ad-
ventitia to the media and intima leading to venous steno-
sis formation [9]. Reduced neointimal formation has been
observed in experimental animal models with the use of
non-specific MMP-2 and MMP-9 inhibitors [11]. We have
shown that there is increased MMP-2 activity at the vein-
to-graft anastomosis with subsequent increased expression
of VEGF-R1 and TIMP-1 [9]. Furthermore, a recent lab-
oratory study showed that in clinical specimens removed
from patients with PTFE haemodialysis grafts, there was a
significant increase in the expression of pro MMP-2, pro
MMP-9andTIMP-1whencomparedtocontrolveins[7].In
aggregate, these studies suggest a prominent role of MMPs
in haemodialysis graft failure.
A recent study showed that in patients with end-stage
renal disease, there is an imbalance between endothelial
and smooth muscle progenitor cells [12]. It is hypothesized
that this imbalance may explain the increased incidence
of atherosclerotic cardiovascular disease in these patients
[13]. Blood outgrowth endothelial cells (BOEC) are a sub-
set of circulating progenitor cells that possess an endothe-
lial cell phenotype [14]. They have been shown to have
potential therapeutic effects in experimental animal models
of restenosis after angioplasty [15] and neovascularization
through MMP activation [16]. BOEC may be used to in-
crease neovascularization by angiogenesis and thus reduce
hypoxia. The aim of the present study was to determine the
effect of hypoxia on BOEC and the production of MMPs
and their inhibitors. Next, we determined whether trans-
planting BOEC to the adventitia of PTFE haemodialysis
grafts would reduce venous stenosis formation and hypoxia
by increasing angiogenesis in a porcine model with chronic
renal insufficiency [17]. Because haemodialysis grafts are
used in patients with advanced renal failure and the regu-
lation of the targeted cytokines may be markedly different
in the uraemic milieu, we performed these studies using a
porcinemodelofrenalinsufficiency[6,17].Theexpression
of HIF-1α, MMP and TIMPs at the vein-to-graft anastomo-
sis with immunohistochemical analysis was performed. Fi-
nally, luminal vessel area and blood flow were evaluated
non-invasively by the use of magnetic resonance imag-




BOEC were made either hypoxic or normoxic for 12, 24
and 48 h, and the production of HIF-1α, MMPs and TIMPs
was determined. Seven castrated juvenile male pigs (40–
50 kg, domestic swine, Larson Products, Sargeant, MN,
USA) with chronic renal insufficiency induced by subtotal
renal infarction were used [6,17]. In these animals, autolo-
gous BOEC were transplanted to the adventitia of the vein-
to-graft anastomosis and the subsequent effect on vessel
remodeling was examined in seven pigs with bilateral arte-
riovenous PTFE grafts. Prior to transplantation, autologous
BOEC were stably transduced with a retrovirus carrying
Lac Z for in vivo localization. As shown in Figure 1A,
BOEC were seeded onto nanopore-sized scaffolding and
wrapped around the adventitia of the vein-to-graft anasto-
mosis at the time of graft placement, in contradistinction
to the contralateral side that received only nanopore-sized
scaffolding (control). Animals were subsequently followed
for 14 days following graft placement. Luminal vessel area
and graft patency were determined serially in each animal
at Day 7, and Day 14 after graft placement using MRI
and phase contrast MRA (Figure 1B) [9]. Animals were
sacrificed at Day 14 and tissue specimens from the vein-
to-graft anastomosis of the control and BOEC-transplanted
veins were carefully examined to determine five aspects of
graft pathology and pathophysiology: (1) relative levels of
HIF-1α,MMPandTIMPexpression;(2)identifyingthelo-
cation and ascertaining the quantity of BOEC engraftment;
(3) angiogenesis using a semi-quantitative scoring method;
(4) determination of the quantity of neointima formation;
and (5) luminal vessel area and blood flow by non-invasive
imaging using MRI. One animal was used for the three-
dimensional microscopic computed tomographic analysis.
Appropriate Institutional Animal Care and Use Com-
mittee approval was obtained prior to performing any pro-
cedures on animals. In addition, housing and handling of
the animals was performed in accordance with the Public
Health Service Policy on Humane Care and Use of Labo-
ratory Animals revised in 2000.
Anaesthesia
Prior to all procedures, animals were kept NPO (noth-
ing per oral) for 12 h. They were initially anaesthetizedAdventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts 87
Fig.1. Placementofpolytetrafluoroethylenehaemodialysisgraftandrep-
resentative MRI and PC MRA of venous stenoses. (A) Placement of poly-
tetrafluoroethylene haemodialysis grafts. (B) MRI and PC MRA were
performed in a Day 14 animal with BOEC treatment on the right (white
arrow) and control on the left (yellow arrow). (C) Schematic showing
the location of the vein-to-graft anastomosis used for histology (V1) and
for protein analysis (V2). PTFE = polytetrafluoroethylene, VS = venous
stenosis, GA = grafted artery, CA = control artery, CV = control vein.
with a combination of 5 mg/kg tiletamine hydrochloride
(50 mg/mL) and zolazepam hydrochloride (50 mg/mL),
2 mg/kg xylazine (Bayer, Shawnee Mission, KS, USA) and
0.06mg/kgglycopyrrolategivenintramuscularly.Toinduce
additional anaesthesia, an intravenous (IV) fluid line was
placed in the ear vein for the delivery of zolazepam hy-
drochloride (5 mg/kg) which was also given as needed.
During the procedure, the animals were intubated and
placed on a positive-pressure ventilator delivering oxygen
(3–5 mL/kg) and isoflurane (1–3%). The end-tidal CO2
volume, oxygen saturation, heart rate, electrocardiogram
and blood pressure were monitored throughout the surgical
procedure.
Isolation and characterization of BOEC
Prior to renal artery embolization, 100 mL of blood was
removed from the femoral artery of each pig. BOEC were
isolated and expanded ex vivo as previously described, with
somemodifications[18].Briefly,peripheralbloodmononu-
clear cells were isolated by density gradient centrifugation
with Ficoll-Paque Plus (Amersham Biosciences Corpora-
tion, Piscataway, NJ, USA). Red blood cells were lysed
using a buffer containing 0.1 mM of EDTA, 10 mM of
KHCO3 and 150 mM of NH4Cl. Next, mononuclear cells
were washed with MCDB 131 medium (GIBCO Indus-
tries, Inc., Langley, OK, USA) supplemented with hydro-
cortisone (1 µg/mL, Sigma-Aldrich, St. Louis, MO, USA),
cyclic-AMP (0.5 mM, EMD Biosciences, Inc., San Diego,
CA, USA), amphotericin B (0.25 µg/mL, Sigma-Aldrich)
and VEGF (10 ng/mL, R&D Systems, Minneapolis, MN,
USA). Mononuclear cells were plated at a density of ∼6 ×
106 cells/well on six-well plates coated with rat tail Colla-
gentypeI(R&DSystems)inendothelial growthmedium-2
(EGM-2, Cambrex Corp., Rutherford, NJ, USA).
The cell culture was maintained at 37◦C, 5% CO2 and
20% O2. After 2 days, the media was changed and the
non-adherent cells were removed. After satisfactory initial
growth, the media was subsequently changed every 2–3
days. Between Days 15 and 18, colonies of cells appeared
that exhibited typical endothelial morphology including a
cobblestone pattern. Colonies were passaged and expanded
foranadditional2weeks.Theadherentcellswereharvested
by trypsinization for transplantation.
The late outgrowth BOEC were characterized by a num-
ber of methods including endocytosis of acetylated low-
density lipoprotein (acLDL) and expression of endothe-
lial markers including VEGF-R2, von Willebrand factor
(vWF), endothelial nitric oxide synthase (eNOS), caveolin-
1 and CD-31. For uptake of acLDL, cells were incubated
with acLDL (Molecular Probes, Invitrogen, Carlsbad, CA,
USA) at a concentration of 10 µg/mL in EGM-2 for 4 h.
Cells were washed with PBS and examined using fluores-
cent confocal microscopy at an absorption wavelength of
555 nm (acLDL).
Indirect immunofluorescence was performed to deter-
mine the expression of endothelial markers as follows.
Briefly, cells were plated in Lab-TEK chamber slides and
cultured at 37◦C under normal culture conditions for 48 h
or until cells were nearly confluent. Media was removed
and cells were washed in warm PBS and then fixed in 4%
paraformaldehyde for 15 min at 37◦C for detection of ex-
tracellular antigen. For detection of intracellular antigens,
cells were washed in cold methanol at 20◦C for 15 min.
Next, cells were blocked with a solution of 5% normal goat
serum (NGS), 5% glycerol in PBS for 1 h at room temper-
ature (RT). Tissue was incubated with a primary antibody
suspended in PBS, 0.1% Tween 20, 0.1% bovine serum
albumin (BSA) and Triton 0.1% for 1 h at RT. After in-
cubation, cells were washed three times in PBS, followed
by incubation with secondary antibody suspended in Tris
buffered saline, with 0.1% Tween 20 (TBS-T) and 0.1%
BSA. Cells were washed three times with PBS, followed
by addition of mounting media containing DAPI (VECTA
shield) and examined by conventional and confocal fluo-
rescence microscopy.
The following antibodies were used: CD31 (Antigenix,
Huntington Station, NY, USA, APG311, 1:100), CD14
(Antigenix, APG140, 1:10), CD45 (Antigenix, APG450-
F, 1:10), α-smooth muscle actin (Lab Vision, Fremont,
CA, USA, RB-9010, 1:100), e-NOS/NOS type III (BD
Transduction Laboratories, San Diego, CA, USA, clone
3, 610296, 1:200) and caveolin (BD Transduction Labora-
tories, 610059, 1:200). The following secondary antibodies
were used: goat anti-mouse Alexa-fluor 568 (Molecular
probes, A-11004, 1:300), goat anti-rabbit (Molecular
probes, A-11036, 1:200) and goat anti-rabbit FITC
(Sigma-Aldrich, F-1262, 1:200).88 D. Hughes et al.
BOEC protein expression in vitro under hypoxic conditions
To determine whether BOEC will secrete MMP proteins in
response to hypoxia, BOEC were cultured under hypoxic
andnormoxicconditionsfor12,24and48h.Briefly,BOEC
were grown to 80% confluence and then placed in a water-
jacketed CO2 incubator that maintains a sub-ambient O2
level (3%) by the regulated injection of N2 (Hera Cell 150).
Control cells were placed in a similar incubator that main-
tained the ambient O2 level (20%). After the appropriate
amount of time, cells were placed on ice and stimulation
was halted by the addition of ice-cold PBS. Cells were
washed three times with ice-cold PBS and lysed with a
cold radioimmunoprecipitation buffer (20 mM Tris–HCl,
pH 7.5, 0.15 MnCl, 1% Triton Z-100, 1 mM phenylmethyl-
sulfonyl fluoride, 1 mM Na3VO4,1m ME D T A ,1µg/mL
leupeptin, 0.5% aprotinin and 2 µg/mL pepstatin A). Cell
lysatesandconditionedmediawerecollectedaftercentrifu-
gation for 15 min at 4◦C and stored at −80◦C for western
blot and zymographic analyses. Experiments were repeated
three times.
Culture of BOEC and nanopore scaffolding
BOEC were cultured with the polyglycolic acid nanopore
scaffolding prior to in vivo experiments to determine if
there were any changes in cell morphology or growth char-
acteristics. Briefly, porcine BOEC from passage 3 were
seeded at a density of 2 × 104, plated onto collagen type
I coated tissue in 12-well plates and cultured for 48 h in
EGM-2 full growth media in the presence of sterilized
5 × 5 mm polyglycolic acid scaffolding. Control wells con-
tained BOEC seeded at an equal density with EGM-2 only.
After24h,cellswereexaminedunderlightmicroscopyfol-
lowed by trypsinization and counted with hemocytometer.
Cellcountswerereportedasmean±SD.Experimentswere
repeated in quadruplicate.
Preparation of retrovirus and transduction of BOEC
To allow for in vivo localization, BOEC were stably trans-
duced with a retrovirus encoding Lac Z. Briefly, the retro-
virus was prepared by seeding 293 T, human embryonal
kidney cells at a density of ∼6 × 106 cells per 100 mm
platein7mLoffullgrowthmediacontainingDMEM(Me-
diatech Inc., Herndon, VA, USA) with 10% fetal bovine
serum and 1× penicillin/streptomycin. DNA transfection
was carried out usingthe effectene TMtransfectionreagent
kit (Qiagen, Valencia, CA, USA). For each 100 mm plate,
2 mg of pMMp-LacZ, 1.5 mg of PMD.MLV gag.pol and
0.5 mg of pMD.G DNA that encode the cDNAs of the pro-
teins required for viral packaging were mixed in 300 mL
of Buffer EC (Qiagen, Valencia, CA, USA). Thirty-two mi-
croliters of enhancer (Qiagen, Valencia, CA) was added
to the DNA mixture and incubated at RT for 2 min. Next
30 µL of effectene was added to the mixture, followed by
10-min incubation at RT. To this, 2.6 mL of full growth
media was added. The DNA/media mixture was added in a
dropwise fashion to each plate of 293T cells. The medium
was changed after 16 h. The retrovirus was isolated 48 h
after transfection and used immediately or frozen for future
use at −80◦C. Three days prior to surgical transplantation
of cells, BOEC from passage 3 or 4 were seeded onto T125
flasks and grown to 50% confluence. For viral transduc-
tion, 8 mL of reduced media, containing EBM, 0.1% FBS,
1× penicillin/ampicillin and 10 ng/mL of VEGF, 8 mL of
viral solution, 10 mg/mL of polybrene was added to each
flask. After 8 h, an additional 15 mL of full growth media
(EGM-2) was added, followed by a change in media after
16 h.






Haemodialysis grafts were placed as previously described
with the following modifications [6,9,20]. Twenty-eight
days after the renal artery embolization procedure, bilat-
eral arteriovenous PTFE graft (4 mm diameter by 7 cm
long, Gore, Flagstaff, AZ, USA) were placed from either
the right or left carotid artery to the ipsilateral jugular vein
(Figure 1A). On the ipsilateral vein-to-graft anastomosis,
BOEC were seeded onto polyglycolic acid scaffolding (see
later) that was placed around the adventitia while the con-
tralateral side received polyglycolic acid scaffolding alone
(control). These animals were killed at 14 days and the
bilateral grafts with accompanying artery and vein were
snap frozen in liquid nitrogen and stored at −80◦Cf o r
Western blotting, zymography and histological analyses.
One day prior to graft placement, all animals were given
anti-platelet therapy by using Plavix (75 mg, Clopidogrel
bisulfate,Sanofi-Aventis, Bridgewater, NJ,USA)bymouth
that was continued until completion of the study. One day
before graft placement and for 5 days after graft place-
ment, the pigs were given antibiotics to prevent infection as
previously described [9,17,19].
Adventitial transplantation of BOEC
To insure effective delivery of BOEC to the adventitia,
we used a polyglycolic acid nanopore scaffolding that had
BOEC seeded onto it directly as described by Godbey et al.
[21]. The polyglycolic acid scaffolding was prepared from
a density of 64 mg/cm3, porosity of 95% and a thickness
of 2.5 mm as previously described [21]. At the time of
graft placement, BOEC, which were previously transfected
with Lac Z retrovirus 3–4 days earlier, were removed by
trypsinization and counted. Five million BOEC cells were
suspended in 500 µL of EGM-2. This mixture was seeded
directly onto the sterile 15 × 10 mm polyglycolic acid
scaffolding, and then sutured loosely around the adventitia
ofthevein-to-graftanastomosis.Onthecontralateralsideto
serve as a control, scaffolding with 500 µLo fE G M - 2w a s
absorbed onto the inner surface and loosely sutured around
the adventitia of the vein-to-graft anastomosis (Figure 1A).Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts 89
Cine phase-contrast magnetic resonance imaging and
contrast-enhanced magnetic resonance angiography
(PC MRI/MRA)
To assess vascular remodeling of the BOEC-transplanted
vessels and control vessels, MRI was performed as de-
scribed previously, at the vein-to-graft anastomosis of
BOEC-transplantedandcontrolvessels[9,20,22].MRIwas
performed serially in all animals at 7 and 14 days following
graft placement. Luminal vessel area, blood flow and graft
patency were determined using MRI. Our laboratory has
used MRI in the past and the accuracy and reproducibility
of MRI for measuring blood flow and area are described
elsewhere [9,20,22]
Vessel harvesting
The vein-to-graft anastomosis, ∼2 cm proximal and cepha-
lad to the stenosis, was removed as previously described
[6,9,21]. These specimens were snap frozen in liquid nitro-
gen and stored at −80◦C for subsequent western blotting,
zymography and immunohistochemical analysis.
Western blot and SDS-PAGE zymography
ToassessangiogenesisandMMPexpression,weusedWest-
ern blotting and zymography on whole tissue lysate, cell
lysate and conditioned media as previously described. One
hundred micrograms of protein (tissue) and 15 µg of cell
lysate were used. Immunoreactive signals were detected
by ECL methods (Amersham Pharmacia Biotech, Piscat-
away, NJ, USA) following the manufacturers instructions.
Antibodies and antisera used included: HIF-1α (Novus
Biochemicals, Littleton, CO, USA, Mouse anti-human),
VEGF-A (Santa Cruz Biotechnology, SC-7269, Mouse
anti-human), VEGF-R1 [Santa Cruz Biotechnology, SC-
504, Rabbit anti-human (C-1158), LotG1505], VEGF-R2
[Santa Cruz Biotechnology, SC-316, Lot F2204, Rabbit
anti-human (C-17)], TIMP-1 (R&D Systems, Clone no.
63515, Mouse IgG2B) and TIMP-2 (R&D Systems, Clone
no. 127711, Mouse IgG1). Zymography was performed on
whole tissue lysate, cell lysate and conditioned media as
previously described [9,20].
Histological and morphometric analysis
To quantify the intima-to-media ratio, haematoxylin and
eosin (H & E) and Verhoeff’s van Giesen (VVG) staining
were performed on 5-µm frozen sections on the vein-to-
graft anastomosis as previously described [9,20]. Sections
were obtained from the vein-to-graft anastomosis as shown
in Figure 1C. Care was taken to include the cushioning
and shoulder regions. Ten contiguous axial sections were
obtained so that the lumen of the vein-to-graft anastomosis
wascircularandtheaverage valueofall10readingsperan-
imal was used [9,20,23]. To determine the location and de-
greeofengraftmentoftheBOEC,frozenslideswerestained
forβ-gal(beta-Gal,Stratagene,LaJolla,CA,USA)accord-
ing to manufacturer’s instructions. Fifteen sample sections
from the vein-to-graft anastomosis of both the control and
BOEC-transplanted vessels were stained for β-gal. Indi-
rect immunofluorescence was performed for CD31, eNOS,
α-smooth muscle actin, MMP-2 and MMP-9.
Quantitative image analysis
Sections stained for β-gal, CD31 and VVG stains were
quantified as previously described [9,19]. For β-gal index,
the entire neointima or normal intima was selected inter-
actively; the area of Lac Z-positive (blue) was captured, by
setting the appropriate RGB (red–green–blue) color inten-
sity threshold. The β-gal index was obtained by calculating
theareaofpositiveβ-galoverthetotalareaoftheneointima
or intima. The neointima and intima were determined from
the VVG-stained sections as previously described [9,19].
Adventitial angiogenesis
The amount of adventitial angiogenesis was quantified us-
ing the CD31 index. This was calculated by counting the
number of positive CD31 cells per area/total cell number
of cells per area in the adventitia adjacent to media, using
theinteractiveKS400imageanalysissoftwareasdescribed
previously [9]. This was blinded to prevent observer bias,
and repeated twice to ensure that intraobserver variabil-
ity was <10%. For each animal with a patent graft, the
CD31 index in the adventitia, adjacent to the media, at the
vein-to-graft anastomosis was measured from the BOEC-
transplanted and non-transplanted vessels.
Three-dimensional microscopic computed tomography
preparation and procedure
Three-dimensionalmicroscopiccomputedtomographywas
performed in order to determine if the vasa vasorum of the
jugular vein communicates with the vasa vasorum of the
carotid artery as previously described [24]. A 6-cm sec-
tion of carotid artery and the accompanying jugular vein
were excised from a pig. A cannula was introduced into the
carotid artery and heparinized saline was infused to clear
any remaining blood from the vasculature. Microfil, a ra-
diopaque polymer, was infused into the artery at a pressure
of 100 mmHg and the distal end of the artery was clamped.
The pressure was maintained until the polymer set. The
sample was then fixed in 10% formalin. The microfil was
removed from the lumen of the carotid artery; the specimen
wasencasedinparaffinandthenscannedusingmicroscopic
computed tomography as previously described [24].
Statistical methods
The luminal vessel area was obtained from the phase-
contrast MRI with MRA and averaged for each time point
for the vessels and for the cardiac cycle for each animal.
Values are expressed as mean ± standard deviation (SD).
Paired t-tests were used to compare the BOEC and control
sides of the vessel. A P value ≤0.05 was considered statis-
tically significant. SAS version 9 (SAS Institute Inc., Cary,
NC, USA) was used for statistical analyses.90 D. Hughes et al.
Fig. 2. HIF-1α expression as a function of time in the BOEC cells dur-
ing hypoxia at different time points. (A) Graph (upper) representing ap-
propriate protein band of HIF-1α from Western blot analysis and graph
(lower) representing appropriate band for IgG from Western blot for pro-
tein loading. N is normoxia and H is hypoxia. (B) Semiquantitative anal-
ysis for HIF-1α performed at 12, 24 and 48 h. The normalized density
of HIF-1α was significantly higher in hypoxic specimens when compared
to normoxic specimens at all time points. ∗A significantly higher value
(P < 0.05). Data are mean ± SD.
Results
Characterization of BOEC and culture with scaffolding
BOEC colonies appeared between Days 15 and 18 and ex-
hibited the typical ‘cobblestone’ appearance of endothelial
cells. Cells demonstrated uptake of acetylated LDL and
stained positive for CD31, vWF, eNOS and caveolin-1.
They were negative for CD14 and α-SMA. Cell popula-
tion purity was estimated to be 95%. After 48 h of cul-
ture of BOEC with nanopore scaffolding, cells maintained
their endothelial morphology. Cell doubling was 3.28 ±
1.6 and 2.88 ± 1.4 for control and nanopore scaffolding,
respectively, indicating that the nanopore scaffolding had
no significant effect on cell-doubling times.
Protein expression of hypoxic and normoxic BOEC
To assess the effects of hypoxia on protein production by
BOEC, BOEC from passage 3 were harvested. Signifi-
cantly increased amount of HIF-1α was observed in hy-
poxic BOEC when compared to normoxic BOEC at 12, 24
and 48 h (Figure 2, P < 0.05). By 12 h, BOEC produced
significantly increased amounts of pro MMP-2 when com-
pared to normoxic BOEC (Figure 3, P < 0.05). No active
MMP-2 or MMP-9 was observed. There was a significant
increase in the production of TIMP-2 by BOEC at 12 h
when compared to normoxic BOEC (Figure 4, P < 0.05).
No difference in TIMP-1 expression was observed at any
of the time points. These results suggest that hypoxia may
be an important stimulus for up-regulation of pro MMP-2
and TIMP-2 in BOEC.
Fig. 3. Pro MMP-2 expression by BOEC under hypoxic conditions at
different time points. (A) Graph (upper) representing appropriate protein
band of pro MMP-2 from zymographic analysis. N is normoxia and H
is hypoxia. (B) Semiquantitative analysis for HIF-1α performed at 12, 24
and 48 h. The normalized density of pro MMP-2 was significantly higher
in hypoxic specimens when compared to normoxic specimens at 12 h. ∗A
significantly higher value (P < 0.05). Data are mean ± SD.
Fig.4. TIMP-2expressionbyBOECunderhypoxicconditionsatdifferent
time points. (A) Graph (upper) representing appropriate protein band of
TIMP-2 from Western blot analysis and graph (lower) representing appro-
priate band for IgG from Western blot for protein loading. N is normoxia
and H is hypoxia. (B) Semiquantitative analysis for TIMP-2 performed
at 12, 24 and 48 h. The normalized density of TIMP-2 was significantly
higher in hypoxic specimens when compared to normoxic specimens at
12 h. ∗A significantly higher value (P < 0.05). Data are mean ± SD.
Surgical outcomes
Seven castrated juvenile male pigs weighing 48.6 ± 1.2 kg
underwent total embolization of the left kidney (7) and
partial embolization of the right kidney (2 upper pole and
5 lower poles) using 150- to 250-µm polyvinyl acrylide
particles in all animals. There were no complications as
a result of the embolization procedure other than the ex-
pected induction of renal insufficiency. The average BUN
and creatinine was 19.6 mg/dL and 2.78 mg/dL, respec-
tively. The normal BUN is 6–21 mg/dL and creatinine is
0.8–1.2 mg/dL. Five pigs had bilateral placement of PTFE
grafts. BOEC were transplanted on the right in one pig andAdventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts 91
Fig. 5. Verhoeff’s van Giesen staining was performed at the venous steno-
sis (section V1, see Figure 1C) from the cushioning region of the BOEC-
transplanted (A and C) and contralateral non-transplanted (control) veins
(B and D). A and B are 5× and C and D are 40× magnification. The
lower panel (E) shows that there was a 50% decrease in the intima-to-
mediaratiointheBOEC-transplantedsampleswhencomparedtocontrols
(P < 0.05). Data are mean ± SD.
ontheleftinfourpigswiththecontralateralvesselsserving
as controls (Figure 1A and B). To determine the effects of
the nanopore scaffolding on protein expression, two pigs
had bilateral PTFE grafts placed with nanopore scaffolding
with Lac Z virus alone wrapped around the adventitia of
the vein-to-graft anastomosis.
Histological and morphometric analysis
Examination of the VVG-stained vein-to-graft anastomo-
sis removed from the BOEC-transplanted vessels revealed
a decrease in the neointima (Figure 5A) when com-
paredtothecontralateralnon-transplanted(control)vessels
(Figure 5B). The intima-to-media ratio was determined for
the vein-to-graft anastomosis of both BOEC-transplanted
and non-transplanted vessels. The mean intima-to-media
ratio of the transplanted BOEC vessels (5.5 ± 1.8) was
50% less than the control (11.4 ± 2.2, P < 0.05). Sev-
eral important observations were made (Figure 5C). Ex-
amination of the adventitia at high-powered magnification
(20×) revealed that the nanopore scaffolding was partially
degraded with individual fibres found in the outermost ad-
ventitiallayer.Therewasnoevidenceofinflammatorycells
withtheexceptionofanoccasionalgiantcell(macrophage)
seen in areas with degraded scaffolding.
Microvessels were seen primarily in the adventitia of
the BOEC-transplanted vessels and contralateral non-
transplanted (control) vessels, occasionally in the intima
and rarely in the media (Figure 6A). Immunostaining was
performed to determine the cell phenotype of the adven-
titial microvessels. This revealed that the cells were pos-
itive for both CD31 (Figure 6A) and eNOS (Figure 6D)
and α-SMA. The neointima of both grafts was composed
primarily of α-SMA cells with the rare CD31-positive
cells (Figure 6A-B). Normal vein is shown for comparison
(Figure 6C and E). In general, the presence of microvessels
appeared more frequently in areas adjacent to neointima,
as opposed to normal intima. These findings indicate that
maturing blood vessel formation had occurred within the
14-day period.
To quantify the degree of angiogenesis, the number
of CD31-positive cells was determined per high-power
field (20×) for both the BOEC-transplanted (Figure 7A)
and the contralateral non-transplanted (control) vessels
(Figure7B).TheCD31densitywasslightlyhigherinthead-
ventitia of BOEC-transplanted vessels (0.17 ± 0.02) when
compared to the contralateral non-transplanted (control)
vessels (0.13 ± 0.03, P = 0.12, Figure 7C). These changes
suggest that transplantation of BOEC enhances angiogene-
sis.
Engraftment of BOEC in the vessel wall was determined
by beta-galactosidase staining for Lac Z. Lac Z-positive
cells were observed in <1% of the adventitial microves-
sels of the BOEC-transplanted vessels (Figure 8A), with
no Lac Z-positive cells in the adventitia of the contralateral
non-transplanted (control) vessels (Figure 8B). In addition,
Lac Z-positive cells were observed in both the neointima
and intima of the BOEC-transplanted vessels (Figure 8A)
and contralateral non-transplanted (control) vessels
(Figure 8B). Engraftment of BOEC was twofold higher
in the neointima and intima of the contralateral non-
transplanted (control) vessel when compared to the ipsilat-
eral BOEC-transplanted neointima and intima (Figure 8C).
Althoughthismaybeimportant,statisticalsignificancewas
not observed possibly due to the small sample size and low
degree of engraftment. No Lac Z-positive cells were seen
in the media. No Lac Z-positive cells were observed in the
carotid artery of both vessels. We interpreted these results
to indicate that the transplanted BOEC may have gained
access to the systemic circulation in one of two ways: (i)
theymayhavemigratedthroughthemediaandintimaofthe
transplanted vessel or (ii) they may have accessed the sys-
temic circulation through the vasa vasorum of the vein that
communicates with the arterial vasa vasorum (see later).92 D. Hughes et al.
Fig. 6. Confocal triple immunostaining of the vein-to-graft anastomosis with transplanted BOEC from a Day 14 animal (A,B). For comparison, (C)
is a normal vein. Blue denotes cell nuclei, green α-SMA and red CD31-positive cells. A shows that CD31-positive cells are lining the adventitial
microvessels (∗) surrounded by α-SMA-positive cells. (B) The neointima is composed primarily of α-SMA-positive cells. Ad is the adventitia, M is the
media, N is the neointima and L is the lumen. For comparison, normal vein is shown in C. L is the lumen, I is the intima and M is the media. (D)A
confocal double immunostaining of eNOS-positive cells (red) from BOEC-transplanted vessels. (E) A normal vein for comparison.
Temporal protein expression of the vein-to-graft
anastomosis
The average HIF-1α expression (Figure 9A and C) de-
creased significantly in the transplanted BOEC vessels
when compared to the contralateral non-transplanted (con-
trol) vessels (P = 0.0475). There was a significant increase
in pro MMP-9 (P = 0.043) and a significant increase in ac-
tive MMP-9 activity (P = 0.05, Figure 9B and C) in trans-
planted BOEC vessels when compared to the contralateral
non-transplanted (control) vessels. No significant differ-
ences in pro MMP-2, active MMP-2, TIMP-1 and TIMP-2
wereobserved. Inthefourgraftsremoved fromthetwoani-
malswithonlynanoporescaffoldingandLacZvirusplaced
around the vein-to-graft anastomosis, only pro MMP-9 was
observed with no active MMP-9. These findings suggest
that activation of MMP-9 was not due to the presence
of scaffolding but resulted from the transplantation of the
BOEC. Tissue immunostaining was performed with an an-
tibody that recognized both the pro and active MMP-9.
This revealed positive staining in the adventitial microves-
sels (Figure 9D). The highest degree of staining was in the
neointima (Figure 9E) of both the BOEC-transplanted and
non-transplanted (control) vein (Figure 9F) with a slightly
higherdegreeofpositivestainingintheBOEC-transplanted
vein. Overall, these results show that the major difference
inproteinexpressionbetweennon-transplantedandBOEC-
transplanted vessels is the presence of active MMP-9.
Luminal vessel area measurements by MRI
MRI was performed to determine the luminal vessel area
of the vessels over time in the animals. The mean luminal
vessel area for the BOEC-transplanted vessels was higher
for all subsequent time points (P = NS). There was no
differenceinthebloodflowbetweenthetransplantedBOEC
and control vessels.
Three-dimensional microscopic computed tomographic
imaging analysis
Three-dimensional microscopic computed tomographic
analysis was performed on intact carotid artery and jugular
vein to determine if the vasa vasorum of the jugular vein
communicateswiththatofthecarotidarteryasitdoesinthe
coronary circulation [25]. This revealed a diffuse network
of vasa vasorum that allowed for the passage of microfil
from the arterial lumen into the adjacent venous lumen.
The observation that Lac Z-positive BOEC cells were ob-
served by Day 14 in both the neointima of the vein-to-graft
anastomosis of the ipsilateral transplanted BOEC and the
contralateral transplanted vessels raises the possibility that
the BOEC may have gained access to the systemic blood
supply (circulating) and homing to the neointima. Three-
dimensional microscopic computed tomographic analyses
demonstrated that the vasa vasorum is a possible route byAdventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts 93
Fig. 7. Indirect immunofluorescence for CD31-positive cells was per-
formed at the venous stenosis from BOEC grafted (A) and control spec-
imens (B). Ad is adventitia, M is the media and L is the lumen, and the
yellow arrow shows microvessel formation. Lower panel shows quantita-
tive assessment from the venous stenosis from BOEC and control grafts.
There was increased amount of CD31-positive cells in the BOEC samples
when compared to the controls.
which cells in the venous adventitia can readily enter the
systemic circulation (Figure 10).
Discussion
The mechanisms underlying the progression of venous
stenosis in patients with haemodialysis vascular access
grafts have not been well defined but are felt due to multi-
plefactors,includingchangesinhaemodynamicparameters
that include wall shear stress and physiologic changes due
to mixing of oxygenated and deoxygenated blood resulting
inlocalvesselhypoxia[5].Angiogenesishasbeenobserved
at sites of intimal hyperplasia in clinical and experimental
studies. Hypoxia activates several cytokines that are impli-
catedintheangiogenicprocessandrecentlyhasbeenshown
to be associated with haemodialysis graft failure [6]. In the
present paper, we showed that hypoxia causes BOEC to
increase the production of both pro MMP-2 and TIMP-2.
Adventitial transplantation of BOEC to the vein-to-graft
anastomosis at the time of haemodialysis graft placement
had several important effects on the BOEC-transplanted
vessels:(1)significantreductioninneointimalhyperplasia,
(2) a significant reduction in tissue expression of HIF-1α,
(3) a significant increase in pro and active MMP-9 activ-
ity, (4) enhancement of adventitial angiogenesis and (5)
engraftment of BOEC to adventitial microvessels.
Fig. 8. Staining for β-gal was performed at the vein-to-graft anastomo-
sis removed from the BOEC and contralateral non-transplanted (control)
specimens. In (A), L is the lumen, N is the neointima, M is a microvessel
and A is adventitia. B is a high magnification of the adventitia. (A)E n -
graftment of Lac Z-positive labeled BOEC cells (blue) into the neointima
(N).In(B),thereisengraftmentofLacZ-positivecellsintothemicrovessel
(yellow arrows) in the adventitia. Lower panel shows quantitative analysis
of the Lac Z-positive BOEC cells into the neointima and intima of both
the transplanted and non-transplanted contralateral (control) vein-to-graft
anastomosis. There was an increase in the engraftment of Lac Z-positive
cells into the neointima of the control vein-to-graft anastomosis when
compared to the BOEC.
Hypoxia is a fundamental stimulus for angiogenesis. It
has been shown to mediate gene expression of several im-
portant angiogenic factors through increased expression of
HIF-1α including VEGF-A, VEGFR-1, MMP-2 and oth-
ers [5]. All of these proteins have been hypothesized to
cause haemodialysis graft failure. A recent study from our
laboratory showed that there was significantly increased
expression of HIF-1α in tissue removed from the venous
stenosiswhencomparedtocontrolveinsinaporcinemodel
[6]. Moreover, in clinical specimens removed from patients
with PTFE haemodialysis grafts, there was significantly
increased expression of HIF-1α when compared to control
veins [7]. In the present study, we investigated the role of
hypoxia on protein production by BOEC and showed that
under hypoxic conditions, BOEC increased the production
of both pro MMP-2 by 12 h and TIMP-2 by 24 h when
compared to normoxic conditions. Increased up regulation
of TIMP-2 has been shown to decrease cell invasion [26].
Severalinvitrostudieshavedemonstratedincreasedexpres-
sion of active MMP-9, by endothelial cells in response to
inflammatory cytokines [27], oscillatory shear stress [28],
by smooth muscle cells in response to cytokines [29] and
constitutively by inflammatory cells [30].
Multiple investigators have shown that circulating bone
marrow-derived progenitor cells functionally contribute to94 D. Hughes et al.
Fig. 9. Graph representing appropriate protein band HIF-1α (A) from
western blot analysis and pro and active MMP-9 from zymography
(B) with blood outgrowth endothelial cell (BOEC) delivery compared
to control (C). According to semiquantitative analysis, by Day 14, the
normalized density of HIF-1α was significantly less in the BOEC samples
whencomparedtocontrol(P<0.05)whilethenormalizeddensityofboth
pro and active MMP-9 was significantly higher than the control vessels
(P < 0.05). (D), (E) Confocal double immunostaining of MMP-9-positive
cells (red) from BOEC-transplanted vessels and (F) the contralateral non-
transplanted (control) vessel. Ad is the adventitia, M is the media, N
is the neointima and L is the lumen. ∗An adventitial microvessel sur-
rounded by cells expressing MMP-9. More intense immunostaining was
observed in the neointima of the transplanted vessels when compared to
non-transplanted vessels.
angiogenesis during hypoxic pathology such as limb is-
chemia [31] and myocardial infarction [32]. However, few
investigators have targeted the adventitia directly. Target-
ing the adventitia is technically easier because BOEC can
be transplanted to the site of injury without significant
washout of cells, as can occur with intraluminal delivery.
This technique has many benefits and can be expanded
to other experimental vascular injury models such as vein
bypass grafts used as arterial conduits, arterial restenosis
after angioplasty and stent placement, and atherosclerosis
in which the adventitia has been implicated in neointima
formation. Transplantation of BOEC was performed by a
unique method to promote engraftment of the progenitor
cellsbyusingbiodegradablenanoporescaffoldingwrapped
aroundtheadventitiaofthevein-to-graftanastomosisatthe
time of graft placement resulting in a significant decrease
in HIF-1α in the transplanted vessels when compared to
control vessels.
ThechangesinproteinexpressioninBOEC-transplanted
vessels suggest several potential mechanisms by which
BOECmayhavepromotedfavorablevenousremodeling.A
significant increase in the expression of both pro and active
MMP-9 was observed in the BOEC-transplanted vessels
when compared to control vessels. Previous work from this
laboratory in both a rat and a porcine model of haemodia-
lysis grafts has shown no evidence of active MMP-9 in ve-
nous stenosis formation [9,19] and in clinical specimens as
well [7]. Furthermore, no active MMP-9 was observed in
venous stenotic tissue removed from animals with bilateral
PTFE grafts with scaffolding and virus alone (no BOEC),
suggestingthatthepresenceofactiveMMP-9wasduetothe
transplantation of BOEC and not the scaffolding. Immuno-
histochemistry of the BOEC-transplanted vessel localized
MMP-9 to the adventitia, media and neointima with the
highest expression in the neointima. Given the low degree
of incorporation of Lac Z-positive cells into the adventi-
tia (<1%) and neointima (1–2%), these findings suggest
that BOEC may act through a paracrine mechanism to up-
regulate the expression of MMP-9 and conversion to its
active form.
Fig. 10. Three-dimensional microscopic computed tomographic evaluation of the carotid artery and jugular vein. (A) A pig carotid artery cross section
showing the lumen and the origin of a vasa vasorum externa with microfilm (box). Yellow arrow is shown in (B). (B) The arterial vasa vasorum (red) and
the venous vasa vasorum (blue) with the yellow arrow on the vasa vasorum from (A). (C) The vasa vasorum surrounding the vein that communicates
with the arterial vasa vasorum.Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts 95
Ithasbeenshownrecentlythatadventitialfibroblastswill
convert to myofibroblasts and migrate into the neointima
contributing to venous stenosis formation [9,23]. Further-
more, it has been shown in fibroblasts harvested from the
pulmonary artery, that hypoxia will stimulate the conver-
sion of fibroblasts to myofibroblasts [33]. It is possible that
the BOEC may have acted on fibroblasts by decreasing
the conversion of fibroblasts to myofibroblasts through a
MMP-2/TIMP-2-mediated pathway. Recently, it has been
shown that increased TIMP-2 will decrease the ability of
cells to invade in breast carcinoma [26]. Further experi-
ments need to be performed to confirm this hypothesis.
ActiveMMP-9hasbeensuggestedtobethekeymediator
in the angiogenic switch [34], a term used to describe the
transitionfromanavasculartumourtoanangiogenicpheno-
type[35].MMP-9hasbeenshowntohavearoleincapillary
branching and is required for adequate angiogenic revascu-
larization of ischaemic tissue [36]. Activation of MMP-9
increasesthebioavailabilityofVEGF-A[34]throughdirect
cleavage of VEGF-A, releasing it from its matrix-binding
motif and converting it to the soluble form [37]. In the
present study, despite increased adventitial angiogenesis in
the BOEC-transplanted vessels, no significant elevations
in VEGF-A were seen. The VEGF-A detected by West-
ern blot analysis is likely matrix-bound VEGF-A rather
than the soluble form. Increased levels of active MMP-9
may have increased the conversion of VEGF-A from the
matrix bound form to soluble form and therefore may
not be detected. Alternatively, VEGF-A levels may have
peaked at an earlier time point or other angiogenic factors
may have been involved. These findings suggest a possible
MMP-9-mediated mechanism by which BOEC promotes
angiogenesis.
MMP-9 has been shown to play a role in aneurysmal
formation through active secretion by smooth muscle cells
and macrophages [38]. There was minimal inflammation
observed at the vein-to-graft anastomosis with the excep-
tion of a rare macrophage seen in the adventitia adjacent to
degraded scaffolding. No evidence of aneurysm formation
was observed by MRI and there was no difference in me-
dial thickness between the BOEC-transplanted vessel and
the contralateral non-transplanted (control) vessels. This
suggests that the changes seen in luminal vessel area were
a result of a decrease in neointima formation but not from
aneurysmal formation.
A trend toward increased angiogenesis was observed
in BOEC-transplanted vessels with engraftment of Lac
Z-positive BOEC into the adventitial microvasculature at
2 weeks. Additionally, Lac Z-positive BOEC were present
in the neointima of both the ipsilateral transplanted BOEC
vesselsandcontralateralnon-transplanted(control)vessels,
but no Lac Z-positive cells were visualized within the me-
dia.ItispossiblethatmigrationoftheLacZ-positiveBOEC
into the media may have occurred prior to the 2 weeks.
Alternatively, BOEC may have entered the systemic circu-
lation via the vasa vasorum that communicates between the
carotid artery and external jugular vein as demonstrated by
the three-dimensional microscopic computed tomographic
analysis.




mal cell-derived factor-1 (SDF-1) that increased the adhe-
sion, migration and homing of circulating progenitor cells
to ischaemic tissue [39]. Interestingly, SDF-1 and MMP-9
have been shown to be involved in cell homing [40]. The
results of the present study suggest that homing and en-
graftment of BOEC to neointima may be regulated through
the elevated HIF-1α levels and hypoxia. However, other
mechanisms mediated through SDF-1 may play a role in
cell homing.
Inconclusion,ourstudyprovidesevidencetosuggestthat
transplantation of BOEC to the adventitia of vein-to-graft
anastomosis of haemodialysis grafts reduces venous steno-
sis formation. There was a decrease in HIF-1α suggesting
alleviation of hypoxia and increased production of active
andproMMP-9suggestingapossiblemechanismbywhich
BOEC may enhance angiogenesis. Additional experiments
need to be performed to confirm these observations as well
as the durability of these early results. Adventitial targeting
has many potential therapeutic applications in cell-based
gene therapy and can be expanded to other experimental
vascular injury models including vein bypass grafts, arte-
rial restenosis after angioplasty and stent placement, and
atherosclerosis.
Limitations
The aim of the present study was to examine the effects
of adventitial delivery on haemodialysis graft remodeling.
Examination of protein expression focused on basic factors
known to play a role in angiogenesis and smooth muscle
cell migration. However, there are many other potential cy-
tokines and haemodynamic stimuli that contribute to these
processes. The contribution of these to venous stenosis in
ourmodeliscurrentlyunderinvestigation.Additionally,the
current study was not designed to examine the effects of
BOEC engraftment to the neointima as this was somewhat
of an unexpected finding. Whether BOEC engraftment to
the neointima promotes or attenuates the progression of
neointima formation remains unclear and will need to be
addressed in future studies. Finally, the durability of the
observed results is unknown because of the short duration
the animals were followed.
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